Shanghai RAAS Blood Products Co Ltd
SZSE:002252

Watchlist Manager
Shanghai RAAS Blood Products Co Ltd Logo
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Watchlist
Price: 7.54 CNY -2.46% Market Closed
Market Cap: 99.7B CNY
Have any thoughts about
Shanghai RAAS Blood Products Co Ltd?
Write Note

Net Margin
Shanghai RAAS Blood Products Co Ltd

21.4%
Current
29%
Average
-7.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
21.4%
=
Net Income
1.8B
/
Revenue
8.3B

Net Margin Across Competitors

Country CN
Market Cap 99.7B CNY
Net Margin
21%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 300.2B USD
Net Margin
9%
Country US
Market Cap 159.1B USD
Net Margin
13%
Country US
Market Cap 126.6B USD
Net Margin
-5%
Country US
Market Cap 114.6B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 137.3B AUD
Net Margin
18%
Country US
Market Cap 87.6B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 34.1B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for Shanghai RAAS Blood Products Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
21.4%
=
Net Income
1.8B
/
Revenue
8.3B
What is the Net Margin of Shanghai RAAS Blood Products Co Ltd?

Based on Shanghai RAAS Blood Products Co Ltd's most recent financial statements, the company has Net Margin of 21.4%.